A Side-by-Side Comparison of Wildtype and Variant Melanocortin 1 Receptor Signaling with Emphasis on Protection against Oxidative Damage to DNA.

DNA damage cAMP extracellular signal-regulated kinases 1 and 2 (ERK1/2) melanocortin 1 receptor (MC1R) melanoma proliferation signaling variant MC1R

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Sep 2023
Historique:
received: 26 07 2023
revised: 11 09 2023
accepted: 18 09 2023
medline: 4 10 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Common variants of the

Identifiants

pubmed: 37762683
pii: ijms241814381
doi: 10.3390/ijms241814381
pmc: PMC10532403
pii:
doi:

Substances chimiques

Cyclic AMP E0399OZS9N
DNA 9007-49-2
Receptor, Melanocortin, Type 1 0
MC1R protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI22/00404

Références

Nature. 2012 Jan 18;481(7381):287-94
pubmed: 22258607
Int J Mol Sci. 2020 May 29;21(11):
pubmed: 32485940
J Invest Dermatol. 2023 Oct;143(10):2019-2029.e3
pubmed: 37142186
Pigment Cell Melanoma Res. 2014 Sep;27(5):721-33
pubmed: 24814217
Pigment Cell Melanoma Res. 2011 Jun;24(3):479-89
pubmed: 21410905
Free Radic Biol Med. 2017 Jun;107:110-124
pubmed: 28109890
Nat Commun. 2016 Jul 12;7:12064
pubmed: 27403562
Hum Mol Genet. 1995 Feb;4(2):223-30
pubmed: 7757071
Genes Dev. 2019 Aug 1;33(15-16):983-1007
pubmed: 31123060
Pigment Cell Melanoma Res. 2013 Nov;26(6):835-44
pubmed: 23962207
Mol Cancer Res. 2012 Jun;10(6):778-86
pubmed: 22622028
Oncogene. 2018 Jul;37(27):3631-3646
pubmed: 29622793
J Invest Dermatol. 2020 Mar;140(3):537-543
pubmed: 31812278
Annu Rev Genet. 2003;37:67-90
pubmed: 14616056
DNA Repair (Amst). 2019 Apr;76:60-69
pubmed: 30818170
Arch Biochem Biophys. 2014 Dec 1;563:28-34
pubmed: 25111671
Cancer Manag Res. 2018 May 14;10:1143-1154
pubmed: 29795986
Pigment Cell Res. 2000 Feb;13(1):4-14
pubmed: 10761990
Front Genet. 2016 May 31;7:95
pubmed: 27303435
FEBS Lett. 2009 Oct 6;583(19):3269-74
pubmed: 19755124
Sci Signal. 2018 Nov 06;11(555):
pubmed: 30401788
Pigment Cell Res. 2004 Aug;17(4):386-95
pubmed: 15250941
Bio Protoc. 2021 Nov 20;11(22):e4225
pubmed: 34909446
Hum Mol Genet. 2007 Sep 15;16(18):2249-60
pubmed: 17616515
Cancer Res. 2006 Oct 1;66(19):9483-91
pubmed: 17018604
Pigment Cell Melanoma Res. 2021 Jul;34(4):748-761
pubmed: 33884776
J Exp Clin Cancer Res. 2017 Oct 11;36(1):142
pubmed: 29020973
Science. 2007 Nov 30;318(5855):1418-23
pubmed: 17947548
Endocrinology. 1996 May;137(5):1627-33
pubmed: 8612494
Nature. 2012 Nov 15;491(7424):449-53
pubmed: 23123854
J Invest Dermatol. 2006 Jan;126(1):172-81
pubmed: 16417234
J Biol Chem. 2007 Feb 2;282(5):3241-51
pubmed: 17130136
JAAD Int. 2021 Jan 04;2:98-108
pubmed: 34409358
Adv Protein Chem Struct Biol. 2019;115:247-295
pubmed: 30798934
Oncogene. 2002 Nov 14;21(52):8037-46
pubmed: 12439754
Ann Transl Med. 2017 Oct;5(19):387
pubmed: 29114545
Genes Dev. 1993 Mar;7(3):454-67
pubmed: 8449404
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13845-50
pubmed: 23908401
Pigment Cell Melanoma Res. 2021 Jan;34(1):72-88
pubmed: 32608114
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
Hum Mutat. 2008 Aug;29(8):E88-94
pubmed: 18484624
J Invest Dermatol. 2022 Feb;142(2):293-302.e1
pubmed: 34362555
Genes (Basel). 2021 Jul 19;12(7):
pubmed: 34356109
Pigment Cell Melanoma Res. 2014 Mar;27(2):244-52
pubmed: 24387634
Pigment Cell Melanoma Res. 2014 Sep;27(5):699-720
pubmed: 24807163
Nat Genet. 2012 Sep;44(9):1006-14
pubmed: 22842228
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Int J Cancer. 2011 Oct 1;129(7):1730-40
pubmed: 21128237
Nucleic Acids Res. 2016 Jul 8;44(W1):W267-71
pubmed: 27166368
Cells. 2023 Apr 06;12(7):
pubmed: 37048170
Nat Commun. 2012 Jun 06;3:884
pubmed: 22673911
Cancer Res. 2005 May 15;65(10):4292-9
pubmed: 15899821

Auteurs

Sonia Cerdido (S)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

José Sánchez-Beltrán (J)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

Ana Lambertos (A)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

Marta Abrisqueta (M)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

Lidia Padilla (L)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.

Cecilia Herraiz (C)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

Conchi Olivares (C)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

Celia Jiménez-Cervantes (C)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

José C García-Borrón (JC)

Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria IMIB-LAIB, El Palmar, 30120 Murcia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH